Key points are not available for this paper at this time.
This study provides an estimate of research and development costs for new therapeutic agents based on publicly available data. Differences from previous studies may reflect the spectrum of products analyzed, the restricted availability of data in the public domain, and differences in underlying assumptions in the cost calculations.
Building similarity graph...
Analyzing shared references across papers
Loading...
Olivier J. Wouters
John Brown University
Martin McKee
Preventive Cardiology
Jeroen Luyten
KU Leuven
JAMA
KU Leuven
London School of Hygiene & Tropical Medicine
London School of Economics and Political Science
Building similarity graph...
Analyzing shared references across papers
Loading...
Wouters et al. (Tue,) studied this question.
synapsesocial.com/papers/69d6ff215413bc3de5ab334c — DOI: https://doi.org/10.1001/jama.2020.1166
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: